Login / Signup

Clinical efficacy of CFTR modulator therapy in people with cystic fibrosis carrying the I1234V mutation.

Bat El Bar AlumaJoel ReiterOri EfratiYael BezalelShlomit KelerMoshe AshkenaziAdi DaganYael BuchnikIdo SadrasMalena Cohen-Cymberknoh
Published in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society (2024)
This study supports a clinical benefit for CFTRm therapy in pwCF carrying the I1234V mutation.
Keyphrases
  • cystic fibrosis
  • lung function
  • stem cells
  • mesenchymal stem cells
  • chronic obstructive pulmonary disease
  • cell therapy
  • replacement therapy
  • chemotherapy induced